153 related articles for article (PubMed ID: 22434389)
1. The use of medication against attention deficit hyperactivity disorder in Denmark: a drug use study from a national perspective.
Pottegård A; Bjerregaard BK; Glintborg D; Hallas J; Moreno SI
Eur J Clin Pharmacol; 2012 Oct; 68(10):1443-50. PubMed ID: 22434389
[TBL] [Abstract][Full Text] [Related]
2. The use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspective.
Pottegård A; Bjerregaard BK; Glintborg D; Kortegaard LS; Hallas J; Moreno SI
Eur J Clin Pharmacol; 2013 Mar; 69(3):589-98. PubMed ID: 22811260
[TBL] [Abstract][Full Text] [Related]
3. Early discontinuation of attention-deficit/hyperactivity disorder drug treatment: a Danish nationwide drug utilization study.
Pottegård A; Bjerregaard BK; Kortegaard LS; Zoëga H
Basic Clin Pharmacol Toxicol; 2015 Apr; 116(4):349-53. PubMed ID: 25220739
[TBL] [Abstract][Full Text] [Related]
4. Use of attention-deficit/hyperactivity disorder medication among older adults in Denmark.
Ormhøj SS; Pottegård A; Gasse C; Rasmussen L
Br J Clin Pharmacol; 2018 Jul; 84(7):1505-1513. PubMed ID: 29493809
[TBL] [Abstract][Full Text] [Related]
5. Utilization of Stimulants and Atomoxetine for Attention-Deficit/Hyperactivity Disorder among 5.4 Million Children Using Population-Based Longitudinal Data.
Furu K; Karlstad Ø; Zoega H; Martikainen JE; Bahmanyar S; Kieler H; Pottegård A
Basic Clin Pharmacol Toxicol; 2017 Apr; 120(4):373-379. PubMed ID: 27911044
[TBL] [Abstract][Full Text] [Related]
6. Patterns of methylphenidate use and assessment of its abuse and diversion in two French administrative areas using a proxy of deviant behaviour determined from a reimbursement database: main trends from 2005 to 2008.
Frauger E; Pauly V; Natali F; Pradel V; Reggio P; Coudert H; Thirion X; Micallef J
CNS Drugs; 2011 May; 25(5):415-24. PubMed ID: 21476612
[TBL] [Abstract][Full Text] [Related]
7. The changing prevalence of attention-deficit/hyperactivity disorder and methylphenidate prescriptions: a study of data from a random sample of insurees of the AOK Health Insurance Company in the German State of Hesse, 2000-2007.
Schubert I; Köster I; Lehmkuhl G
Dtsch Arztebl Int; 2010 Sep; 107(36):615-21. PubMed ID: 20948775
[TBL] [Abstract][Full Text] [Related]
8. Prescriptions for ADHD medication, 2004-08.
Lillemoen PK; Kjosavik SR; Hunskår S; Ruths S
Tidsskr Nor Laegeforen; 2012 Sep; 132(16):1856-60. PubMed ID: 22986969
[TBL] [Abstract][Full Text] [Related]
9. The 10-year trend in drug prescriptions for attention-deficit/hyperactivity disorder (ADHD) in Germany.
Grimmsmann T; Himmel W
Eur J Clin Pharmacol; 2021 Jan; 77(1):107-115. PubMed ID: 32803292
[TBL] [Abstract][Full Text] [Related]
10. [Use of methylphenidate among children in Iceland 1989-2006].
Zoëga H; Baldursson G; Halldórsson M
Laeknabladid; 2007 Dec; 93(12):825-32. PubMed ID: 18057472
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, incidence and persistence of ADHD drug use in Japan.
Okumura Y; Usami M; Okada T; Saito T; Negoro H; Tsujii N; Fujita J; Iida J
Epidemiol Psychiatr Sci; 2019 Dec; 28(6):692-696. PubMed ID: 29804548
[No Abstract] [Full Text] [Related]
12. Less discontinuation of ADHD drug use since the availability of long-acting ADHD medication in children, adolescents and adults under the age of 45 years in the Netherlands.
van den Ban E; Souverein PC; Swaab H; van Engeland H; Egberts TC; Heerdink ER
Atten Defic Hyperact Disord; 2010 Dec; 2(4):213-20. PubMed ID: 21258431
[TBL] [Abstract][Full Text] [Related]
13. Patterns of Lisdexamfetamine Dimesylate Use in Children, Adolescents, and Adults with Attention-Deficit/Hyperactivity Disorder in Europe.
Siffel C; Page M; Maxwell T; Thun B; Kolb N; Rosenlund M; von Bredow D; Keja J
J Child Adolesc Psychopharmacol; 2020 Sep; 30(7):439-447. PubMed ID: 32315539
[No Abstract] [Full Text] [Related]
14. Prevalence of and change in the prescription of methylphenidate in Israel over a 2-year period.
Fogelman Y; Vinker S; Guy N; Kahan E
CNS Drugs; 2003; 17(12):915-9. PubMed ID: 12962530
[TBL] [Abstract][Full Text] [Related]
15. Use of drugs for ADHD among adults-a multinational study among 15.8 million adults in the Nordic countries.
Karlstad Ø; Zoëga H; Furu K; Bahmanyar S; Martikainen JE; Kieler H; Pottegård A
Eur J Clin Pharmacol; 2016 Dec; 72(12):1507-1514. PubMed ID: 27586399
[TBL] [Abstract][Full Text] [Related]
16. Latest trends in ADHD drug prescribing patterns in children in the UK: prevalence, incidence and persistence.
Beau-Lejdstrom R; Douglas I; Evans SJ; Smeeth L
BMJ Open; 2016 Jun; 6(6):e010508. PubMed ID: 27297009
[TBL] [Abstract][Full Text] [Related]
17. The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care.
McCarthy S; Wilton L; Murray ML; Hodgkins P; Asherson P; Wong IC
BMC Pediatr; 2012 Jun; 12():78. PubMed ID: 22712630
[TBL] [Abstract][Full Text] [Related]
18. Overlapping Prescriptions of Stimulants for Children and Adolescents With Attention-Deficit Hyperactivity Disorder.
Chen CY; Yeh HH; Fang SY; Wu EC; Chang IS; Lin KM
Psychiatr Serv; 2012 Oct; 63(10):1011-8. PubMed ID: 22911441
[TBL] [Abstract][Full Text] [Related]
19. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study.
Wong IC; Asherson P; Bilbow A; Clifford S; Coghill D; DeSoysa R; Hollis C; McCarthy S; Murray M; Planner C; Potts L; Sayal K; Taylor E
Health Technol Assess; 2009 Oct; 13(50):iii-iv, ix-xi, 1-120. PubMed ID: 19883527
[TBL] [Abstract][Full Text] [Related]
20. Dosage of methylphenidate and traumatic brain injury in ADHD: a population-based study in Taiwan.
Liao YT; Yang YH; Kuo TY; Liang HY; Huang KY; Wang TN; Lee Y; McIntyre RS; Chen VC
Eur Child Adolesc Psychiatry; 2018 Mar; 27(3):279-288. PubMed ID: 28856464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
